# FDA Inspection 1182334 - Lin, James P MD Inc - October 19, 2022

Source: https://www.keypedia.com/records/fda_inspections/lin-james-p-md-inc/dfad97df-b857-4d5e-a783-e7358decf600
Source feed: FDA_Inspections

> FDA Inspection 1182334 for Lin, James P MD Inc on October 19, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1182334
- Company Name: Lin, James P MD Inc
- Inspection Date: 2022-10-19
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1263504 - 2025-03-12](https://www.keypedia.com/records/fda_inspections/lin-james-p-md-inc/62664eb0-bc6b-4b3c-b6f0-faf954ad59a4)
- [FDA Inspection 1182334 - 2022-10-19](https://www.keypedia.com/records/fda_inspections/lin-james-p-md-inc/355362bb-47f1-47f5-a55a-6698cb42f9dc)
- [FDA Inspection 1182334 - 2022-10-19](https://www.keypedia.com/records/fda_inspections/lin-james-p-md-inc/81494077-f152-4283-9f90-f3320b374318)
- [FDA Inspection 1034922 - 2017-10-30](https://www.keypedia.com/records/fda_inspections/lin-james-p-md-inc/c1ba8420-7988-4b2a-ac7a-6b5dd4eaca46)
- [FDA Inspection 1034922 - 2017-10-30](https://www.keypedia.com/records/fda_inspections/lin-james-p-md-inc/27feb3a9-f84b-48a5-b255-3f1de06932aa)

Company: https://www.keypedia.com/companies/lin-james-p-md-inc/c4590b97-dbd4-4dfb-b300-b24667453442

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d